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Reduction of renal blood flow and proximal bicarbonate reabsorption
in rats by gentamicin. Although aminoglycoside-induced acute renal
failure occurs commonly, little is known about the mechanisms which
alter renal hemodynamics. In sodium-depleted Sprague-Dawley rats
treated with gentamicin, we measured RBF and GFR at the onset of this
model of nephrotoxic acute renal failure. After 10 days of sodium
chloride depletion, one group of rats received a single injection of
gentamicin, 100 mg/kg, while control animals received the gentamicin
vehicle. Twenty-four hours later, Pr and UNa/UCr were similar in both
groups. C1 was unchanged, but RBF was reduced significantly (12.40
1.33 vs. 16.89 1.24 mI/mm). Micropuncture studies revealed that
although SNGFR was unchanged, end-proximal and early distal flow
rates were increased significantly. End-proximal TFc1 was reduced
significantly in gentamicin-treated animals when compared to controls
(130.7 3.9 vs. 149.5 4.1 mEq/liter). Early distal TF1 was also
reduced significantly (32.4 2.0 vs. 44.3 1.4 mEq!liter). In other rats,
24 hr after a second injection of gentamicin, Pr and UNa/UCr were
increased significantly and both GFR and RBF were reduced signifi-
cantly. We conclude that the earliest hemodynamic change in gentami-
cm-induced acute renal failure is a reduction in RBF which precedes
any change in GFR. A single dose of gentamicin also impairs proximal
bicarbonate and water reabsorption and reduces end-proximal and early
distal chloride concentration.
Reduction du debit sanguin renal et de Ia reabsorption proximale des
bicarbonates chez des rats par Ia gentamicine. Bien qu'une insuffisance
rénale aiguë induite par les aminoglycosides se produise fréquemment,
on sait peu de choses sur les mécanismes qui altèrent l'hémodynamique
rénale. Chez des rats Sprague-Dawley déplétés en sodium traités par de
Ia gentamicine, nous avons mesuré RBF et GFR au debut de ce modèle
d'insuffisance rénale aigue nephrotoxique. Après 10 jours de dCplétion
en chlorure de sodium, un groupe de rats a recu une injection unique de
gentamicine, 100 mg/kg, tandis que les animaux contrôles recevaient le
solvant de Ia gentamicine. Vingt-quatre heures plus tard, P. et UNa/Ucr
Ctaient identiques dans les deux groupes. C1 était inchangé, mais RBF
était significativement diminuC (12,40 1,33 contre 16,89) 1,24 ml!
mm). Des etudes en microponction ont révélé que bien que SNGFR soit
inchangé, les debits dans l'extrémité du proximal et le debut du distal
étaient significativement augmentes. TF1 a Ia fin du proximal était
significativement réduit chez les animaux traités par Ia gentamicine par
rapport au contrôle (130,7 3,9 contre 149,5 4,1 mEq!litre). TFc1 au
debut du distal était egalement significativement réduit (32,4 3,2
contre 44,3 1,4 mEq/litre). Chez d'autres rats, 24 heures aprés une
seconde injection de gentamicine, PCr et UNa/UCr étaient significative-
ment augmentés, et GFR et RBF étaient significativement diminués.
Nous concluons que Ia modification hemodynamique Ia plus prdcoce au
cours de l'insuffisance rénale aiguë induite par Ia gentamicine est une
diminution de RBF qui précède toute modification de GFR. Une dose
unique de gentamicine altère egalement Ia reabsorption proximale de
bicarbonate et d'eau, et diminue la concentration de chlore a Ia fin du
proximal et au debut du distal.
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Gentamicin-induced acute renal failure is a common clinical
occurrence [1]. The morphologic changes of proximal tubule
necrosis that occur with gentamicin treatment have been well
described in both experimental animals [2—91 and humans [10—
13]. This form of nephrotoxic acute renal failure is predictably
slow in onset and is typically nonoliguric [14, 15]. In addition,
aminoglycoside therapy produces a variety of proximal tubule
dysfunction syndromes including the Fanconi syndrome [16—
18], glycosuria [19], and renal magnesium wasting [20—23].
While many of the morphologic and functional disturbances
that result from gentamicin therapy have been described previ-
ously, those factors that initiate the reduction in GFR and RBF
remain poorly understood. Therefore, the present studies were
designed to investigate the earliest detectable changes in renal
hemodynamics and tubule fluid contents associated with genta-
micin therapy.
Methods
We studied 186 male Sprague-Dawley rats averaging approxi-
mately 350 g in weight (Fig. 1). On day —10, we placed paired
rats into separate metabolic cages. Throughout the experimen-
tal protocol, we weighed the rats daily and pairfed them a
sodium deficient diet (ICN 902902) to magnify the tubulo-
glomerular feedback response [24, 25]. On day 0, we obtained
blood from the tail of warmed rats to determine plasma creati-
nine, sodium, and chloride concentrations. In all animals we
obtained spot urine specimens for sodium and creatinine deter-
minations. We injected the 93 experimental rats with gentami-
cm sulfate (Schering) 100 mg/kg s.c., and the 93 control animals
with equal volumes of the gentamicin diluent (a solution of 5%
dextrose in water). On day 1, 24 hr following this first injection,
we performed micropuncture studies on 16 control and 16
gentamicin-treated rats. Additionally, in 20 control and 20
gentamicin-treated animals, we determined RBF by electro-
magnetic flow probe and by measuring PAH clearance, correct-
ed for PAH extraction. In all of these 36 control and 36
gentamicin-treated animals, we measured both inulin and PAH
clearances by standard techniques. In these same animals, we
determined plasma and urine electrolytes and creatinine con-
centrations. On day 1, we injected the remaining 57 control and
57 experimental animals with a second dose of vehicle or
gentamicin. On the following day (day 2), we performed hemo-
dynamic studies on 20 of the 57 remaining control animals and
20 of the 57 remaining gentamicin-treated animals. In all 114
animals studied on day 2, we again obtained urine and plasma
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Day 0 1st Controlinjection
samples for electrolyte and creatinine determinations and then
sacrificed the remaining 74 animals that were not undergoing
hemodynamic studies.
Micropuncture and clearance studies (32 rats). We anesthe-
tized rats with mactin, 100 mg/kg i.p., and then cannulated a
femoral vein to infuse PAH and 3H-inulin. We inserted an iliac
artery catheter to monitor arterial blood pressure and collect
arterial blood samples. We cannulated both the left ureter and
the bladder to collect urine separately from each kidney. We
then mobilized the left kidney, placed it onto a dish (Lucite®)
and bathed it in mineral oil heated to 37°C. To replace intravas-
cular losses during surgery, we infused a volume of Ringer's
lactate solution equal to 1% of body weight over a 30-mm
period. We then started a sustaining infusion at a rate of 0.22
ml min' kg body weight. The infusion contained 3H-
methoxy-inulin in an amount sufficient to create and maintain,
in the smallest tubule fluid sample collected, a count rate at
three times above the background. The infusion also contained
enough PAH to create and maintain a plasma concentration of
2.5 mg/dl. We waited 1 hr after the start of the maintenance
infusion to allow the animal to equilibrate and then collected
four 60-mm samples to determine C1 and CPAH.
During each 1-hr period, we collected fluid from the end-
proximal and early distal tubules of a single nephron. We
identified end-proximal tubules by their position adjacent to
vascular stars and confirmed this location by noting the disap-
pearance of an oil droplet placed into the tubule following the
collection of both samples. We found distal tubules by injecting
a small volume of a 0.5% solution of green dye (FD&C,
Keystone, Chicago, Illinois) into the end-proximal tubule. In
nephrons containing a surface distal tubule, we identified that
tubule as "early distal" only when dye appeared in its lumen
within 20 to 35 sec from the time of injection into the end-
proximal tubule. We sampled only those nephrons with both
end-proximal and early distal tubules on the kidney surface. We
have described micropuncture collection and measurement
techniques previously [26].
186 d'Rats
pair-fed
Na deficient diet
93
Gentamicin
treated
1St Gentamicin injection
100 mg/kg
16 20 57
Micropuncture '' RBF 2nd Gentamicin
injection, 100mg/kg
Hemodynamic studies. We anesthetized animals undergoing
hemodynamic studies in the same manner as those undergoing
micropuncture and clearance studies. However, in these ani-
mals, we threaded a tapered PE-lO catheter via the right iliac
vein into the left renal vein. We then exposed the left renal
artery and placed a 2-mm internal circumference electromag-
netic flow probe (Carolina Medical) around it to determine renal
blood flow directly. We cannulated the bladder and the left
ureter to determine right and left renal function separately. We
measured inulin and PAH clearances as described above. In
addition, we sampled blood from the left renal vein at the
midpoint of each clearance to determine PAH extraction.
Analytical techniques. We measured the concentration of
chloride in tubule fluid by the amperimetric titration method of
Ramsey, Brown, and Croghan [27]. We measured tritium
activity in plasma, urine and tubule fluid with an IsoCap 300
liquid scintillation system (Nuclear Chicago) using Aquasol II
(New England Nuclear), We analyzed plasma and urine sodium
concentrations with a lithium internal standard flame photom-
eter and chloride concentration with a Buchler chioridometer.
We determined creatinine colorometrically using a modified
Jaffe reaction [281 and PAH by the method of Waugh and Beall
[29].
Calculations. We estimated effective cortical renal plasma
flow from the clearance of PAH and GFR from the clearance of
inulin. We calculated renal plasma flow by dividing PAH
clearance by the PAH extraction ratio. We also determined
RBF directly using an electromagnetic blood flow probe cali-
brated for various hematocrits. We determined mechanical zero
at the end of each study to correct for baseline variation, We
calculated single nephron glomerular filtration rate (SNGFR) as
the product of the TF/P inulin ratio and tubule fluid flow rate.
Statistics. The values reported are means SEM. The micro-
puncture data in Tables 2 and 3 are the averages of the sixteen
micropuncture studies in each group. We averaged the results
of three to five collections to determine a single value for each
of the 32 individual micropuncture studies. We evaluated
Day —10
Control
Day 1
Day 2
57 2016
2nd Control RBF L
injection
3720
Sacrificed RBFFig. 1. Experimental design (see Methods).
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Fig. 2. Plasma creatinine before (day 0) and 24 hr after receiving one
dose (day 1) or two doses (day 2) of gentamicin (lined bars) or vehicle
(open bars). Values are means SE.
differences between means by Student's t test on paired or
unpaired samples as appropriate.
Results
Figure 2 demonstrates the changes in plasma creatinine
concentration in response to two separate injections of gentami-
cm. On day 0, following 10 days of sodium deprivation, there
was no significant difference in the mean plasma creatinine
concentrations (Pcr) of the two groups. Twenty-four hours after
the first injection of vehicle or gentamicin (day 1), again, there
was no significant difference in the mean PC,.of the two groups.
However, the second injection of gentamicin significantly in-
creased the mean Pc,. when compared with the mean value from
control animals on day 2. Figure 3 demonstrates that while two
injections of gentamicin significantly increased the UNa/UCr
ratio (P < 0.001), a single injection failed to produce a signifi-
cant change.
We performed hemodynamic studies on days 1 and 2 to
detect the earliest changes in renal hemodynamics associated
with gentamicin nephrotoxicity. As demonstrated in Table 1,
gentamicin treatment reduced CPAH but not C1,,, after 1 day of
therapy. PAH extraction was not significantly altered at that
time. RBF was reduced significantly as determined by electro-
magnetic flow probe. However, 2 days of gentamicin therapy
reduced both GFR and RBF significantly when compared with
controls.
We performed micropuncture studies on day 1 to determine
whether subtle changes in tubule fluid might be detected at a
time when RBF was decreased but whole-kidney GFR was
unchanged. Similar to the data for the whole kidney, a single
injection of gentamicin did not significantly decrease SNGFR
(Table 2). In both control and gentamicin treated groups,
proximal SNGFR was significantly greater than distal SNGFR
(P < 0.01) indicating a functioning tubuloglomerular feedback
system [301. Twenty-four hours after a single injection of
gentamicin, both the end-proximal and early distal tubule fluid
flow rates (V) were increased. The fraction of filtered water in
the end-proximal and early distal tubule samples was also
increased after a single injection of gentamicin (reflected by the
significant decreases in the TF/P inulin ratios). As demonstrat-
ed in Table 3, this decrease in water reabsorption was associat-
ed with a significant reduction in both TFc1 and TF/Pc1 in fluid
from end-proximal and early distal tubules. Treatment with
gentamicin did not alter plasma sodium or chloride concentra-
tions when compared with controls.
Extracellular fluid volume as reflected by total body weight
was not significantly different between the two groups. On day
1, at the time of study, the 93 control animals weighed 310 26
g and the 93 experimental animals weighed 302 15 g.
Following the second injection, on day 2, the 57 control animals
weighed 295 20 g and the 57 gentamicin-treated animals
weighed 272 13 g. These differences were not statistically
significant. In addition, there was no significant difference in
the mean arterial blood pressures of the two groups on days 1
and 2.
Discussion
Aminoglycoside therapy remains an important form of hospi-
tal-acquired acute renal failure. Despite the common occur-
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Fig. 3. Urine sodium to creatinine ratios before (day 0) and 24 hr after
receiving one dose (day 1) or two doses (day 2) of gentamicin (lined
bars) or vehicle (open bars). Values are means SE.
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Table 1. Renal hemodynamic data after the first (day 1) and second (day 2) injection of gentamicin or its solvent vehicle (control)a
Cia CPAH
EAH
RBFb
mi/mmmI/mm
Day I
Control 1.85 0.24 6.10 0.35 0.62 0.04 16.89 1.24
N 36 36 20 20
Gentamicin 1.91 0.12 5.01 0.31 0.68 0.06 12.40 1.33
N 36 36 20 20P NS <0.025 NS <0.02
Day 2
Control 1.79 0.24 5.16 0.68 0.64 0.07 14.66 1.67N 20 20 20 20
Gentamicin 1.03 0.11 2.60 0.54 0.62 0.04 7.62 1.48N 20 20 20 20
P <0.001 <0.001 NS <0.01
a Means SE are used for values obtained from the left kidney.
b RBF was determined by electromagnetic flow probe.
Table 2. Single nephron GFR (SNGFR), tubule fluid flow rate ('J), and the ratio of tubule fluid to plasma inulin concentration at end-proximal
and early distal tubule sites in control and gentamicin-treated rats 24 hr after a single injection (day l)a
SNGFR, ni/mm '', ni/mm TF/P Inulin
Proximal Distal Proximal Distal Proximal Distal
Control 55.8 3.8 42.3 3.2 17.2 1.8 5.3 0.5 3.1 0.2 7.8 0.8
(N = 16)
Gentamicin 53.5 4.2 40.5 3.5 23.8 1.5 8.4 0.8 2.3 0.2 5.1 0.4
(N = 16)
P NS NS <0.01 <0.01 <0.01 <0.01
a Means SE.
rence of gentamicin-induced renal failure, the specific mecha-
nisms that alter renal hemodynamics and reduce GFR are still
incompletely understood. However, several factors that con-
tribute to these changes have been identified. For example,
acute tubular necrosis after gentamicin therapy has been well
described by many investigators in both experimental animals
and humans [2—13]. In addition, Baylis, Rennke, and Brenner
[31] have reported that 10 days of gentamicin therapy signifi-
cantly reduces glomerular filtration by decreasing the glomeru-
lar capillary ultrafiltration coefficient (Kf) in the Munich-Wistar
rat. Furthermore, Neugarten, Aynedjian, and Bank [32] have
suggested a role for intratubular obstruction following 4 days of
gentamicin therapy. In the present study, we demonstrate that a
reduction in RBF is the earliest hemodynamic manifestation of
gentamicin-induced acute renal failure and precedes significant
changes in GFR. We also describe concomitant changes in
proximal and distal tubule fluid chloride concentrations.
There are numerous means by which gentamicin might re-
duce RBF. For example, stimulation of a tubuloglomerular
feedback mechanism has been suggested to be important in
reducing RBF in acute renal failure, but this premise is contro-
versial [33]. Mason demonstrated tubuloglomerular feedback to
be intact at the onset of acute renal failure of various types, but
the relevance of this observation to the hemodynamic changes
of acute renal failure is uncertain [30]. Neither the stimulus nor
the mediator of the tubuloglomerular feedback mechanism has
been unequivocally identified in either normal animals or in
animals with acute renal failure. It has been suggested that an
increase in chloride concentration at the macula densa might be
the stimulus which decreases RBF in acute renal failure [33,
34]. The present study does not address all of these controver-
sies. It does explore the relationship of distal tubule chloride
concentration to the decreasing renal blood flow of gentamicin-
induced acute renal failure. This reduction occurs at a time
when the tubuloglomerular feedback mechanism is intact. In
this setting, the chloride concentration in the distal tubule is
decreased but distal tubule flow rate and total distal chloride
delivery are increased. These observations neither prove nor
disprove a role for tubuloglomerular feedback in reducing RBF
in acute renal failure. They do suggest, however, that if
tubuloglomerular feedback is involved in this model, then,
contrary to previous suggestions, it is not stimulated by an
increase in distal chloride concentration. Although many con-
troversies concerning the role of tubuloglomerular feedback in
acute renal failure remain unresolved, the model we describe
here may prove useful for further study.
Angiotensin has also been suggested to be an important
mediator of changes in renal hemodynamics in acute renal
failure. In particular, angiotensin has been implicated in genta-
micin-induced acute renal failure. Schorr et al have suggested a
possible role for angiotensin II by demonstrating that treatment
with the angiotensin converting enzyme inhibitor captopril
partially corrects the previously reported [35] effects of genta-
micin on Kf, SNGFR, and glomerular plasma flow rate. Al-
though these previous observations suggest an increase in renin
and angiotensin II production, those factors which stimulate
renin release and the sites which mediate the increase in renal
resistance remain unclear. The results of the present study are
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Table 3. Plasma sodium and chloride concentrations 24 hr following a single injection of gentamicin or its solvent vehicle (control); tubule fluid
(TF) chloride concentrations and the ratio of TF/P chloride from end-proximal and early distal sitesa
PNa
mEqiliter
'DCI
mEqi/iter
TF1, mEqi/iter TF/P1
Proximal Distal Proximal Distal
Control 144.4 6.8 107.9 6.1 149.5 4.1 44.3 1.4 1.39 0.07 0.41 0.03
(N = 16)
Gentamicin 146.3 8.2 112.7 5.3 130.7 3.9 32.4 2.0 1.10 0.06 0.28 0.02
(N = 16)
P NS NS <0.01 <0.001 <0.01 <0.01
a Means SE.
also consistent with a role for angiotensin II in that gentamicin
treatment produced an early reduction in RBF without a
significant reduction in GFR when compared to controls.
Although control RBF, GFR, and SNGFR results appear
somewhat elevated, the animals used in the present study are
larger than those used in most previously reported micropunc-
ture studies.
The present study also demonstrates that a single injection of
gentamicin produces a significant impairment in proximal tu-
bule function. Twenty-four hours following a single dose of
gentamicin, the experimental animals exhibited abnormal water
reabsorption manifested by an increase in flow rate and a
significant decrease in the TF/P inulin ratio of fluid obtained
from end-proximal and early distal tubules. Furthermore, gen-
tamicin appears to impair bicarbonate reabsorption in the
proximal tubule and this increase in bicarbonate may account
for the impairment in water reabsorption. Normally, chloride
concentration rises along the proximal tubule while bicarbonate
is preferentially reabsorbed [36—391. However, in these genta-
micin-treated animals, the end-proximal chloride concentration
was reduced significantly strongly suggesting impaired bicar-
bonate reabsorption. Early distal chloride concentration was
also lowered. Since bicarbonate reabsorption is negligible in the
loop of Henle [40, 411, bicarbonate may act as a poorly
reabsorbed anion and impair water and chloride reabsorption in
this segment of the nephron as well [40, 42]. Thus, in this
model, gentamicin lowers chloride concentration in the proxi-
mal and distal tubule, and because of impaired water reabsorp-
tion, gentamicin may alter osmolality as well (although this was
not measured in the present study).
In conclusion, we demonstrate that the earliest hemodynamic
manifestation of gentamicin-induced acute renal failure is a
reduction in renal blood flow which occurs prior to any change
in GFR. While a single injection of gentamicin produces an
increase in renal resistance, the sites of these resistance
changes and the mechanisms by which these changes occur
remain unknown. We further demonstrate that a single injection
of gentamicin decreases the chloride concentration in the end-
proximal and early distal tubules 24 hr later, as a result of
impaired proximal bicarbonate and water reabsorption. These
changes occur at a time when RBF is reduced and GFR is
unchanged. A second injection of gentamicin produces a reduc-
lion in both RBF and GFR.
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